Business / Finance

RSS

Bioxodes completes seed funding round to bring Ir-CPI product into pre-clinical development

Bioxodes SA, a company developing products derived from natural sources, has completed a EUR 2.6 million (USD 3.5 million) first seed funding round with a consortium of business angels and Belgian investment funds. EUR 1.6 million is from the European Regional Development Fund and the Walloon Region in Belgium via the Retech program for Research and Technology. It will be used to bring the company’s lead product Ir-CPI into pre-clinical development over the next 18 months.

27 Nov 2013

QRxPharma refiles MOXDUO New Drug Application with US FDA

QRxPharma Limited announced today that the Company resubmitted its MOXDUO New Drug Application. At a meeting in early October, the United States Food and Drug Administration provided QRxPharma with guidance on its requirements for the NDA refiling as well as data validation documentation.

26 Nov 2013

Purlife inks deal with Canada-based auto warranty company

Neutra Corp. (OTCBB: NTRR), a growing provider of all-natural wellness solutions, is proud to announce that its partner, Purlife, has signed a deal with one of Canada's largest automotive warranty companies to make its revolutionary Drivepur Protection System available to a network of 1,200 car dealerships.

26 Nov 2013

New collaborative effort to advance MEMS technologies for key applications

A*STAR Institute of Microelectronics (IME), GLOBALFOUNDRIES Singapore Pte. Ltd., and Masdar Institute of Science and Technology (MI) have entered into a collaboration to develop and advance micro-electro-mechanical systems (MEMS) technologies for automotive, aerospace, consumer, healthcare, industrial, and mobility applications.

26 Nov 2013

Medworxx files Financial Statements and Management's Discussion and Analysis report for Q3 2013

Medworxx Solutions Inc. ("Medworxx"), a leader in clinical patient flow, and compliance and education solutions, announced today it has filed with the Canadian securities authorities its Consolidated Financial Statements and Management's Discussion and Analysis report for the three and nine month interim periods ended September 30, 2013.

26 Nov 2013

Transgene welcomes SillaJen’s intention to acquire Jennerex

Transgene SA (Paris:TNG) said today that it welcomed the announcement by SillaJen, Inc. of its intention to acquire Jennerex, Inc. and has consequently given its consent to the definitive merger agreement.

26 Nov 2013

DKMS selects Remedy Informatics to provide analytics and pattern recognition technology

Remedy Informatics, Inc., the leading provider of registry-based informatics software for life sciences research and healthcare delivery, announced that DKMS, the world's largest bone marrow donor center, has selected Remedy's informatics solutions to solidify its position as an innovator and leader of hematopoietic stem cell transplantation worldwide.

26 Nov 2013

Nepstar's revenue increases 7.7% to RMB683.2 million in third quarter 2013

China Nepstar Chain Drugstore Ltd.("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the third quarter ended September 30, 2013.

26 Nov 2013

Nepstar declares annual cash dividend of US$0.32 per ADS

China Nepstar Chain Drugstore Ltd. ("Nepstar" or the "Company"), the largest retail drugstore chain in China based on the number of directly operated stores, today announced that the Board of Directors has declared an annual cash dividend of US$0.32 per American Depositary Share (ADS), which represents a total value to shareholders of approximately US$31.59 million.

26 Nov 2013

SillaJen executes definitive merger agreement to acquire Jennerex

SillaJen, Inc., a privately-held biotherapeutics and contract research company focused on the development of targeted biological products for cancer, announced today that it had executed a definitive merger agreement to acquire San Francisco-based Jennerex, Inc.

26 Nov 2013

Immune Pharmaceuticals to transfer common stock listing from NASDAQ OMX Stockholm Exchange

Immune Pharmaceuticals Inc. announced today that its common stock has been approved for trading on NASDAQ OMX First North Premier, Stockholm ("First North").

26 Nov 2013

Ansell reaches agreement to acquire BarrierSafe Solutions International

Ansell Limited, a global leader in protection solutions, today announces that it has reached an agreement to acquire BarrierSafe Solutions International ("BarrierSafe"), a leading North American provider of single-use gloves, for a total consideration of approximately US$615 million, subject to certain adjustments (the "Acquisition"), from Odyssey Investment Partners and others.

26 Nov 2013

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Celgene International Sàrl, a wholly-owned subsidiary of Celgene Corporation, today announced that the European Medicines Agency's: Committee for Medicinal Products for Human Use has adopted a positive opinion for ABRAXANE (paclitaxel formulated as albumin bound nanoparticles, or nab-paclitaxel) in combination with gemcitabine for first-line treatment of adult patients with metastatic adenocarcinoma of the pancreas.

25 Nov 2013

Nutranomics joins Genesar Nutraceuticals to acquire worldwide licence for GenEpic

Nutranomics, Inc. is pleased to announce that the Company has completed a Licence Agreement with Genesar Nutraceuticals, LLC to acquire the worldwide exclusive marketing and distributing rights to GenEpic, a natural therapeutic treatment formula currently the subject of an IRB reviewed phase II human clinical study on prostate cancer treatment and recovery.

25 Nov 2013

Patient Safety Technologies announces closing of $5 million senior secured term loan

Patient Safety Technologies, Inc. today announced the closing of a $5 million senior secured term loan. At close, $4 million of the term loan was funded. The Company has the ability to draw an incremental $1 million under the term loan, subject to certain conditions. The five-year term loan matures in 2018 and bears interest at 13% per annum.

22 Nov 2013

Covagen, TRL expand research collaboration to generate bispecific FynomAb

Covagen and Tanabe Research Laboratories U.S.A, Inc., a fully owned subsidiary of Mitsubishi Tanabe Pharma Corporation, today announced that they expanded their strategic research collaboration. MTPC and TRL have nominated a first bispecific FynomAb for formal preclinical development which triggered an undisclosed milestone payment. MTPC and TRL also exercised an option for a second bispecific FynomAb program based on the parties' research and licensing agreement signed in October 2012.

21 Nov 2013

Vect-Horus, AAA form scientific collaboration to open new avenues in treatment of brain diseases

Vect-Horus, a French company specialized in the development of vector molecules for the central nervous system, announces today it has signed a scientific collaboration agreement with Advanced Accelerator Applications, a fast growing international player in Molecular Nuclear Medicine. The financial terms of the deal have not been disclosed.

20 Nov 2013

RAS, Sutter Health join to provide medical care and services for patients in greater Sacramento region

Sutter Health and Radiological Associates of Sacramento have agreed to join forces in providing diagnostic imaging and radiation oncology services across the greater Sacramento region.

20 Nov 2013

LabStyle Innovations, InnoMed ink distribution agreement for Dario blood glucose monitoring device

LabStyle Innovations Corp., developer of Dario, a cloud-based, mobile health platform for diabetes and related blood glucose monitoring, announced today that it has entered into an exclusive agreement with InnoMed Ltd. to distribute the Dario diabetes management platform's blood glucose monitoring device in New Zealand. The terms of the agreement were not disclosed.

20 Nov 2013

AGA, Covidien partner to improve lives of people struggling with digestive diseases

The American Gastroenterological Association Institute announced today that Covidien, a leading global provider of health-care products, recently agreed to expand its corporate grant to the AGA Institute.

19 Nov 2013

Business / Finance

Bioxodes completes seed funding round to bring Ir-CPI product into pre-clinical development

QRxPharma refiles MOXDUO New Drug Application with US FDA

Purlife inks deal with Canada-based auto warranty company

New collaborative effort to advance MEMS technologies for key applications

Medworxx files Financial Statements and Management's Discussion and Analysis report for Q3 2013

Transgene welcomes SillaJen’s intention to acquire Jennerex

DKMS selects Remedy Informatics to provide analytics and pattern recognition technology

Nepstar's revenue increases 7.7% to RMB683.2 million in third quarter 2013

Nepstar declares annual cash dividend of US$0.32 per ADS

SillaJen executes definitive merger agreement to acquire Jennerex

Immune Pharmaceuticals to transfer common stock listing from NASDAQ OMX Stockholm Exchange

Ansell reaches agreement to acquire BarrierSafe Solutions International

CHMP adopts positive opinion for ABRAXANE with gemcitabine for treatment of metastatic pancreas

Nutranomics joins Genesar Nutraceuticals to acquire worldwide licence for GenEpic

Patient Safety Technologies announces closing of $5 million senior secured term loan

Covagen, TRL expand research collaboration to generate bispecific FynomAb

Vect-Horus, AAA form scientific collaboration to open new avenues in treatment of brain diseases

RAS, Sutter Health join to provide medical care and services for patients in greater Sacramento region

LabStyle Innovations, InnoMed ink distribution agreement for Dario blood glucose monitoring device

AGA, Covidien partner to improve lives of people struggling with digestive diseases

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Latest News